Funding Opportunities

 

Proof of Concept Stage

These opportunities focus on research that has the potential for the formation of a startup company.

QED Program

  • The QED Program seeks medical technologies with high commercial potential. The QED program provides key resources, including business guidance, bridge funding, and access to industry and investor representatives, to competitively selected projects.
  • Guidelines for Rutgers Applicatants

NSF PFI:AIR-TT

NSF I-Corps

  • The National Science Foundation's Innovation Corps
  • The primary goal of I-Corps is to foster entrepreneurship that will lead to the commercialization of technology that has been supported previously by NSF-funded research. The vehicle for commercialization activities will most often be start-ups founded by the I-Corps participants; successful I-Corps projects will be prepared for business formation, feeding the SBIR and STTR programs.

Busch Biomedical Grants (internal to Rutgers)

  • The Busch Biomedical Grant program is designed to enhance health-related research at the University and to strengthen the competitive position of faculty members who seek external research funds.

 

Early Stage

Phase 1 Ventures (P1V)

  • P1V is an accelerator partnering with academic inventors to launch new startup companies to commercialize their technologies. The program establishes a new company and provides business expertise, funding and strategic guidance. Each project must submit one or more SBIR, STTR or equivalent funding proposals.

Foundation Venture Capital Group

  • Foundation Venture Capital Group, LLC provides pre-seed funding to new life science companies in New Jersey to help them advance toward commercialization. The Group directly invests in the development of new startup companies helping them to advance emerging medical breakthroughs in research and technology.

 

Established Small Businesses

SBIR / STTR